Showing results (431-440 of 599) with videos related to
Sort By:
Pageof 60
Plos One|August 14, 2013
The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian populationRaphael Borie, Bruno Crestani, Philippe Dieude, et al.Advances in Therapy|November 11, 2023
Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT StudyMarc Schmalzing, Herbert Kellner, Ayman Askari, et al.Frontiers in Medicine|March 6, 2020
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort StudyClaudio Tirelli, Valentina Morandi, Adele Valentini, et al.Annals of the Rheumatic Diseases|December 21, 2012
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational studyMuriel Elhai, Marine Meunier, Marco Matucci-Cerinic, et al.Plos One|October 6, 2016
Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR StudyVeronika K Jaeger, Elina G Wirz, Yannick Allanore, et al.Journal of Scleroderma and Related Disorders|January 8, 2025
Longitudinal association between nailfold capillaroscopy and incident interstitial lung disease: A EUSTAR database analysisArthiha Velauthapillai, Jeska K de Vries-Bouwstra, Joerg Henes, et al.Arthritis and Rheumatism|April 12, 2011
C8orf13-BLK is a genetic risk locus for systemic sclerosis and has additive effects with BANK1: results from a large french cohort and meta-analysisBaptiste Coustet, Philippe Dieudé, Mickael Guedj, et al.The Journal of Rheumatology|January 17, 2017
Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for ScreeningMaria-Grazia Lazzaroni, Ilaria Cavazzana, Enrico Colombo, et al.Arthritis & Rheumatology (Hoboken, N.J.)|August 15, 2017
Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic SclerosisJérôme Avouac, Christophe Guignabert, Anna Maria Hoffmann-Vold, et al.Seminars in Arthritis and Rheumatism|November 6, 2017
Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, FranceJérôme Avouac, Anna Moltó, Vered Abitbol, et al.Pageof 60